Get the Stockscreener App
1.45
4.61%
-0.07
Salarius Pharmaceuticals Inc Stock (SLRX) Forecast
The Salarius Pharmaceuticals Inc (SLRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $131.34, representing a +8,958% increase from the current price of $1.45. The highest analyst price target is $132.97, and the lowest is $129.71.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SLRX Price Target
Average 161.73
(+11,054% Upside)
Is Salarius Pharmaceuticals Inc (SLRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.98 | Neutral |
| STOCH(9,6) | 51.32 | Neutral |
| STOCHRSI(14) | 68.91 | Neutral |
| MACD(12,26) | -0.0377 | Buy |
| ADX(14) | 10.45 | Neutral |
| William %R | -55.36 | Neutral |
| CCI(14) | 69.76 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.423
Buy
|
1.4543
Sell
|
| MA20 |
1.458
Sell
|
1.4778
Sell
|
| MA50 |
1.5387
Sell
|
1.5855
Sell
|
| MA100 |
1.7748
Sell
|
1.9283
Sell
|
| MA200 |
2.8695
Sell
|
2.7848
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, SLRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 9 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on SLRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.98 indicates that SLRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 51.32 indicates that SLRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.91 indicates that SLRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 10.45 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 69.76 indicates that SLRX is still overbought but not to an extreme extent.
Long-term SLRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Salarius Pharmaceuticals Inc financial reports and earnings history, Salarius Pharmaceuticals Inc (SLRX) stock could reach $237.96 by 2030, $168.95 by 2040 and $560.69 by 2050. See the projected annual prices until 2050 of the Salarius Pharmaceuticals Inc stock below:
- Salarius Pharmaceuticals Inc (SLRX) is expected to reach an average price of $49.02 in 2035, with a high prediction of $55.78 and a low estimate of $49.05. This indicates an $3,280% rise from the last recorded price of $1.45.
- Salarius Pharmaceuticals Inc (SLRX) stock is projected to chart a bullish course in 2040, with an average price target of $161.27, representing an $11,022% surge from its current level. The forecast ranges from a conservative $161.51 to a sky-high $168.95.
- Our analysts predict Salarius Pharmaceuticals Inc (SLRX) to jump 22,408% by 2045, soaring from $327.40 to an average price of $326.36, potentially reaching $335.18. While $327.40 is the low estimate, the potential upside is significant.
- Salarius Pharmaceuticals Inc (SLRX) stock is expected to climb by 2050, reaching an average of $548.47, a $37,725% jump from its current level. However, a wide range of estimates exists, with high and low targets of $560.69 and $549.56, respectively, highlighting the market's uncertainty.
Salarius Pharmaceuticals Inc Stock (SLRX) Year by Year Forecast
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2024
Our forecast for SLRX stock price in 2024 now indicates an average price target of $181.89 with a high forecast of $363.35 and a low forecast of $0.43. The average prediction reflects an increase of +12,444% from the last recorded price of $1.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $127.07 | $129.71 | $132.97 | +8,664% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2025
Salarius Pharmaceuticals Inc Stock (SLRX) is expected to reach an average price of $161.73 in 2025, with a high prediction of $194.87 and a low estimate of $128.60. This indicates an +11,054% rise from the last recorded price of $1.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $126.86 | $128.60 | $122.22 | +8,649% |
| February, 2025 | $156.76 | $131.86 | $145.02 | +10,711% |
| March, 2025 | $194.16 | $171.14 | $194.77 | +13,291% |
| April, 2025 | $194.25 | $192.92 | $194.87 | +13,296% |
| May, 2025 | $193.23 | $193.46 | $192.83 | +13,226% |
| June, 2025 | $183.00 | $185.00 | $185.00 | +12,521% |
| July, 2025 | $162.66 | $164.66 | $172.22 | +11,118% |
| August, 2025 | $159.69 | $161.94 | $163.68 | +10,913% |
| September, 2025 | $164.72 | $162.70 | $159.97 | +11,260% |
| October, 2025 | $168.64 | $166.47 | $165.24 | +11,530% |
| November, 2025 | $164.31 | $165.66 | $164.51 | +11,232% |
| December, 2025 | $164.89 | $162.28 | $162.37 | +11,272% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2026
The predicted value for Salarius Pharmaceuticals Inc (SLRX) in 2026 is set at an average of $135.51. Estimates vary from a peak of $162.20 to a trough of $108.81, indicating an +9,245% surge from the present price of $1.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $160.50 | $161.60 | $162.20 | +10,969% |
| February, 2026 | $153.13 | $152.84 | $159.25 | +10,460% |
| March, 2026 | $140.40 | $143.15 | $148.64 | +9,583% |
| April, 2026 | $106.56 | $108.81 | $136.42 | +7,249% |
| May, 2026 | $124.59 | $126.59 | $122.21 | +8,493% |
| June, 2026 | $124.87 | $123.74 | $122.11 | +8,512% |
| July, 2026 | $121.78 | $127.02 | $126.13 | +8,299% |
| August, 2026 | $122.31 | $123.16 | $120.31 | +8,335% |
| September, 2026 | $122.73 | $122.09 | $120.82 | +8,364% |
| October, 2026 | $122.36 | $124.00 | $122.37 | +8,338% |
| November, 2026 | $114.28 | $115.72 | $119.38 | +7,781% |
| December, 2026 | $110.69 | $110.94 | $110.04 | +7,534% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Salarius Pharmaceuticals Inc (SLRX) is $97.85, with a high forecast of $109.90 and a low forecast of $85.80. This indicates an +6,648% increase from the last price of $1.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $111.46 | $110.77 | $109.32 | +7,587% |
| February, 2027 | $111.14 | $111.09 | $109.90 | +7,565% |
| March, 2027 | $110.53 | $111.61 | $109.70 | +7,523% |
| April, 2027 | $109.43 | $109.76 | $109.62 | +7,447% |
| May, 2027 | $105.78 | $106.91 | $107.59 | +7,195% |
| June, 2027 | $103.80 | $104.33 | $104.09 | +7,058% |
| July, 2027 | $99.94 | $100.10 | $100.88 | +6,793% |
| August, 2027 | $99.67 | $98.71 | $98.78 | +6,774% |
| September, 2027 | $97.49 | $98.09 | $99.19 | +6,623% |
| October, 2027 | $93.61 | $93.99 | $96.48 | +6,356% |
| November, 2027 | $89.66 | $90.02 | $92.15 | +6,083% |
| December, 2027 | $84.85 | $85.80 | $88.77 | +5,752% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2028
In 2028, Salarius Pharmaceuticals Inc (SLRX) is projected to reach an average price of $64.10, with a high projection of $83.83 and a low estimate of $44.36. This indicates an +4,320% rise from the last price of $1.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $81.84 | $82.46 | $83.83 | +5,544% |
| February, 2028 | $78.98 | $79.36 | $81.14 | +5,347% |
| March, 2028 | $77.49 | $77.53 | $77.66 | +5,244% |
| April, 2028 | $73.97 | $74.10 | $76.48 | +5,001% |
| May, 2028 | $70.51 | $70.63 | $73.03 | +4,763% |
| June, 2028 | $65.26 | $66.18 | $69.13 | +4,400% |
| July, 2028 | $62.73 | $62.87 | $64.30 | +4,226% |
| August, 2028 | $58.38 | $58.47 | $61.56 | +3,926% |
| September, 2028 | $55.50 | $55.61 | $57.39 | +3,728% |
| October, 2028 | $51.65 | $51.81 | $54.33 | +3,462% |
| November, 2028 | $47.53 | $47.70 | $50.30 | +3,178% |
| December, 2028 | $44.18 | $44.36 | $46.40 | +2,947% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2029
The 2029 price forecast for Salarius Pharmaceuticals Inc Stock (SLRX) is $107.74 on average, with a high prediction of $214.55 and a low estimate of $0.9331. This represents an +7,331% increase from the previous price of $1.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $40.41 | $40.44 | $43.24 | +2,687% |
| February, 2029 | $36.96 | $37.03 | $39.47 | +2,449% |
| March, 2029 | $33.53 | $33.64 | $36.07 | +2,212% |
| April, 2029 | $30.22 | $30.28 | $32.66 | +1,984% |
| May, 2029 | $25.80 | $25.88 | $29.23 | +1,680% |
| June, 2029 | $22.41 | $22.43 | $24.92 | +1,446% |
| July, 2029 | $18.98 | $19.10 | $21.53 | +1,209% |
| August, 2029 | $14.74 | $14.79 | $18.06 | +916.65% |
| September, 2029 | $11.24 | $11.31 | $13.84 | +675.29% |
| October, 2029 | $6.8588 | $6.8989 | $10.28 | +373.02% |
| November, 2029 | $3.5138 | $3.539 | $5.8629 | +142.33% |
| December, 2029 | $255.18 | $0.9331 | $214.55 | +17,498% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2030
Salarius Pharmaceuticals Inc Stock (SLRX) is expected to reach an average price of $281.31 in 2030, with a high forecast of $412.30 and a low forecast of $150.32. This signifies an +19,301% surge from the last price of $1.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $102.12 | $187.12 | $237.96 | +6,943% |
| February, 2030 | $10.45 | $162.68 | $163.51 | +620.40% |
| March, 2030 | $352.61 | $150.32 | $313.86 | +24,218% |
| April, 2030 | $273.78 | $292.65 | $323.64 | +18,782% |
| May, 2030 | $337.99 | $286.93 | $332.24 | +23,209% |
| June, 2030 | $343.04 | $342.50 | $328.73 | +23,558% |
| July, 2030 | $367.86 | $346.82 | $361.77 | +25,270% |
| August, 2030 | $355.39 | $356.17 | $350.38 | +24,410% |
| September, 2030 | $351.48 | $352.20 | $346.73 | +24,140% |
| October, 2030 | $413.04 | $371.74 | $412.30 | +28,386% |
| November, 2030 | $408.49 | $407.84 | $407.59 | +28,072% |
| December, 2030 | $404.91 | $405.91 | $407.18 | +27,825% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):